News and Media
How to Use Machine Learning in Clinical Research
Clinical research is very complex, mainly because the questions we answer are almost always multivariate problems, and machine learning can aid clinical researchers in making sense of it. Subjects in a clinical trial differ by myriad factors. Age, gender, and weight...
EU Clinical Trials Regulation: The Need for Coordination by Sponsors
Planning, timing, and coordination. These three words may be the magic formula that Sponsors will have to adopt when the European Clinical Trials Regulation comes into force. Sponsors will have to prepare their timelines well to...
Why Every Pharmaceutical Company Needs to Plan for Drug Product Labeling Early in Clinical Studies
For many scientists and healthcare professionals involved in developing new medicines, patients, the people who represent the unmet need, are a primary motivating factor. To ensure that patients and physicians can make full use of a product’s potential, conveying...
On-Demand Webinar: Avoiding Common Pitfalls in the IND and CTA Submission Process
[Fill out the form below to register] Abstract: When planning an Investigational New Drug (IND) or Clinical Trial Authorization (CTA) submission, navigating FDA, EMA, and other regulations can be challenging and creating scientifically-sound strategies are...
3 Approaches for Quality Control in the Pharma Industry
Regulatory document quality is of the utmost importance in the pharmaceutical, biotechnology, and medical device industries to ensure data accuracy and provide confidence in drawing reliable conclusions. A great quality control process ensures that the writing is...
Why You Should Update Your Clinical Trial Disclosure Policy for the EU Clinical Trials Regulation and ICMJE Requirements Now
The European Medicines Agency (EMA) recently announced the European Union (EU) Portal, a database for obtaining a clinical trial authorization, will be activated by the end of January 2022. The EU Portal will trigger the enforcement of the EU Clinical Trial...
MMS Holdigns Joins DTRA as A Founding Member to Accelerate The Adoption of Patient- Focused
MMS Holdings Joins Decentralized Trials & Research Alliance (DTRA) as A Founding Member to Accelerate The Adoption of Patient-Focused CANTON, Mich. (January 29, 2021) – MMS Holdings – an award-winning, data-focused CRO – joins a historic alliance of fifty life...
MMS Academy Launches Mobile App for Accessing Pharmaceutical Industry Virtual Learning Courses from Anywhere
CANTON, Mich. (October 28, 2020) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today that its learning arm, MMS Academy, now offers access to all of its virtual pharmaceutical industry courses through a mobile smart device application. As an...
FDA Advisory Committee Meeting Held to Discuss Important Topics Surrounding COVID-19 Vaccines
The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on Thursday, October 22, 2020, to discuss the development, authorization, and/or licensure of vaccines to prevent COVID-19. The committee heard from...
SUBSCRIBE TO UPDATES
Please provide your information to stay informed.
Avery Zimmerman
6880 Commerce Blvd.
Canton, MI 48187 USA
734 245 0310
media@mmsholdings.com